PHARMA DAIVE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA DAIVE
Largest movements
- Current investments +€32,401
up €32,401 (+19.4%), from €166,932 to €199,333
- Cash -€25,503
down €25,503 (-22.1%), from €115,454 to €89,951
mainly Contributions, distributions and other (-€194,315) and Current investments (-€32,401)
- Receivables within one year +€16,323
up €16,323 (+38.7%), from €42,128 to €58,451
of which Trade receivables: +€42,771
- Other debts +€134,501
new in 2024: €134,501
- Contributions -€94,115
down €94,115 (-90.4%), from €104,115 to €10,000
- Profit (loss) carried forward -€77,742
down €77,742 (-86.3%), from €90,077 to €12,336
- Tax, wage and social debts +€44,117
up €44,117 (+400.9%), from €11,005 to €55,122
of which Taxes: +€43,976
- Reserves +€19,231
up €19,231 (+20.3%), from €94,769 to €114,000
of which Distributable reserves: +€29,643
- Financial income +€31,080
up €31,080 (+2158.9%), from €1,440 to €32,519
- Taxes +€16,337
up €16,337 (+328.3%), from €4,976 to €21,314
- Gross operating margin +€11,929
up €11,929 (+18.2%), from €65,502 to €77,430
- Depreciation -€7,075
down €7,075 (-77.7%), from €9,108 to €2,033
- Staff costs +€1,171
up €1,171 (+2.8%), from €42,518 to €43,688
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €385,415 | €407,317 | +€21,902 | +5.7% |
| Fixed assets | 21/28 | €12,562 | €13,130 | +€567 | +4.5% |
| Tangible fixed assets | 22/27 | €12,269 | €12,836 | +€567 | +4.6% |
| Land and buildings | 22 | €861 | €807 | -€54 | -6.3% |
| Plant, machinery and equipment | 23 | €2,739 | €1,901 | -€839 | -30.6% |
| Other tangible fixed assets | 26 | €8,669 | €10,128 | +€1,460 | +16.8% |
| Financial fixed assets | 28 | €294 | €294 | = | 0.0% |
| Current assets | 29/58 | €372,853 | €394,187 | +€21,334 | +5.7% |
| Stocks and contracts in progress | 3 | €43,980 | €43,297 | -€683 | -1.6% |
| Stocks | 30/36 | €43,980 | €43,297 | -€683 | -1.6% |
| Amounts receivable within one year | 40/41 | €42,128 | €58,451 | +€16,323 | +38.7% |
| Trade receivables | 40 | €15,680 | €58,451 | +€42,771 | +272.8% |
| Other amounts receivable | 41 | €26,448 | - | -€26,448 | |
| Current investments | 50/53 | €166,932 | €199,333 | +€32,401 | +19.4% |
| Cash at bank and in hand | 54/58 | €115,454 | €89,951 | -€25,503 | -22.1% |
| Deferred charges and accrued income | 490/1 | €4,359 | €3,155 | -€1,204 | -27.6% |
| Total equity and liabilities | 10/49 | €385,415 | €407,317 | +€21,902 | +5.7% |
| Equity | 10/15 | €288,961 | €136,336 | -€152,626 | -52.8% |
| Contributions | 10/11 | €104,115 | €10,000 | -€94,115 | -90.4% |
| Reserves | 13 | €94,769 | €114,000 | +€19,231 | +20.3% |
| Non-distributable reserves | 130/1 | €10,412 | - | -€10,412 | |
| Reserves not available under the articles | 1311 | €10,412 | - | -€10,412 | |
| Distributable reserves | 133 | €84,357 | €114,000 | +€29,643 | +35.1% |
| Profit (loss) carried forward | 14 | €90,077 | €12,336 | -€77,742 | -86.3% |
| Amounts payable | 17/49 | €96,454 | €270,981 | +€174,527 | +180.9% |
| Amounts payable within one year | 42/48 | €96,454 | €270,981 | +€174,527 | +180.9% |
| Trade debts | 44 | €85,449 | €81,358 | -€4,091 | -4.8% |
| Suppliers | 440/4 | €85,449 | €81,358 | -€4,091 | -4.8% |
| Taxes, remuneration and social security | 45 | €11,005 | €55,122 | +€44,117 | +400.9% |
| Taxes | 450/3 | €5,619 | €49,595 | +€43,976 | +782.6% |
| Remuneration and social security | 454/9 | €5,386 | €5,527 | +€141 | +2.6% |
| Other amounts payable | 47/48 | - | €134,501 | +€134,501 | |
| Remuneration, social security and pensions | 62 | €42,518 | €43,688 | +€1,171 | +2.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,108 | €2,033 | -€7,075 | -77.7% |
| Other operating charges | 640/8 | €709 | €746 | +€37 | +5.2% |
| Gross operating margin | 9900 | €65,502 | €77,430 | +€11,929 | +18.2% |
| Operating profit (loss) | 9901 | €13,167 | €30,964 | +€17,797 | +135.2% |
| Financial income | 75/76B | €1,440 | €32,519 | +€31,080 | +2158.9% |
| Recurring financial income | 75 | €1,440 | €32,519 | +€31,080 | +2158.9% |
| Financial charges | 65/66B | €364 | €480 | +€117 | +32.1% |
| Recurring financial charges | 65 | €364 | €480 | +€117 | +32.1% |
| Profit (loss) for the period before taxes | 9903 | €14,243 | €63,003 | +€48,760 | +342.3% |
| Income taxes | 67/77 | €4,976 | €21,314 | +€16,337 | +328.3% |
| Profit (loss) for the period | 9904 | €9,267 | €41,689 | +€32,423 | +349.9% |
| Profit (loss) for the period to be appropriated | 9905 | €9,267 | €41,689 | +€32,423 | +349.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.